Sequential AC-T is likely to be the most effective adjuvant therapy regimen for early-stage breast cancer regardless of hormone receptor status.
No takes yet. Share an insight, caveat, or question.
Fujii et al. (2015) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: